| Date Filed | Type | Description |
| 10/05/2023 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 222 shares
@ $1.9763, valued at
$438.7 |
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 1,653 shares
@ $2.4955, valued at
$4.1k
|
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 1,557 shares
@ $5.0777, valued at
$7.9k
Sold 338 shares
@ $5.1438, valued at
$1.7k
|
|
| 11/14/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 5,989 shares
@ $8.0021, valued at
$47.9k
Sold 18,011 shares
@ $8.176, valued at
$147.3k
|
|
| 10/26/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 07/06/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 10,500 shares
@ $0
Granted 19,500 options to buy
@ $4.13, valued at
$80.5k
|
|
| 04/22/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 276 shares
@ $6.6843, valued at
$1.8k
|
|
| 04/04/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 17,442 shares
@ $0
Granted 42,558 options to buy
@ $9.15, valued at
$389.4k
|
|
| 01/24/2022 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 1,563 shares
@ $8.7526, valued at
$13.7k
|
|
| 02/23/2021 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Sold 800 shares
@ $43.1363, valued at
$34.5k
|
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Converted 4,361 shares
@ $0
Converted 6,500 convertible preferred
@ $0 |
|
| 07/31/2020 |
4
| Hagen Brett R (Chief Accounting Officer) has filed a Form 4 on Allovir, Inc.|
Txns:
| Granted 43,400 options to buy
@ $17, valued at
$737.8k
|
|
| 07/30/2020 |
3
| Hagen Brett R (Chief Accounting Officer) has filed a Form 3 on Allovir, Inc. |
| 04/05/2017 |
4
| Hagen Brett R (See Remarks) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Granted 21,100 options to buy
@ $7.56, valued at
$159.5k
|
|
| 08/08/2016 |
4
| Hagen Brett R (Principal Accounting Officer) has filed a Form 4 on PROTEOSTASIS THERAPEUTICS, INC.|
Txns:
| Granted 7,500 options to buy
@ $10.8, valued at
$81k
|
|
| 08/08/2016 |
3
| Hagen Brett R (Principal Accounting Officer) has filed a Form 3 on PROTEOSTASIS THERAPEUTICS, INC. |